Pelthos Therapeutics Inc. (PTHS)

Pelthos Therapeutics Revenue

Pelthos Therapeutics had revenue of $15.60M in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to $43.30M. In the year 2025, Pelthos Therapeutics had annual revenue of $16.80M. That makes Pelthos Therapeutics the 28,965th largest company in the world by revenue and 3,880th in the United States.

• Revenue (ttm): $43.30M
• Revenue Growth: n/a
• P/S Ratio: 1.79
• Revenue / Employee: $470,696
• Employees: 92
• Market Cap: 77.56M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Commercial Operations 16.21M 96.5%
• Research and Development Operations 589.00K 3.5%

Fiscal year ended Dec 31, 2025 See the full Pelthos Therapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	16.80M	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error